SCHEMBL5539426

SCHEMBL5539426

CC(C)NC(=O)N1CCCC(NC(=O)C(C)(C)C(C)C)C1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.50
CA2 P00918 4/20 0.50
CA12 O43570 2/20 0.50
CA9 Q16790 2/20 0.50
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 1/20 0.40
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
EPHX2 P34913 1/20 0.37
USP30 Q70CQ3 1/20 0.36
HTT P42858 1/20 0.36
DPP4 P27487 1/20 0.36
KDM5A P29375 1/20 0.36
SIGMAR1 Q99720 2/20 0.35
EPHX1 P07099 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5544456 0.85 ALDH1A1 (0.50) CYP2C9ALDH1A1PKMSMN1; SMN2EPHX2
SCHEMBL10266061 0.81 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2EPHX2USP30HTT
SCHEMBL5514087 0.78 CA1 (0.44) CA1CA2CA12CA9GAA
SCHEMBL14679302 0.76 ALDH1A1 (0.51) CA1CA2CA12CA9ALDH1A1
SCHEMBL18914213 0.76 PDK1 (0.49) GAAALDH1A1PKMSMN1; SMN2EPHX2
SCHEMBL18909863 0.74 PDK1 (0.56) GAAALDH1A1SMN1; SMN2EPHX2SIGMAR1
SCHEMBL14472339 0.72 CA1 (0.49) CA1CA2CA12CA9GAA
SCHEMBL18907740 0.72 PKM (0.48) GAAALDH1A1PKMSMN1; SMN2EPHX2
SCHEMBL12448075 0.71 ALDH1A1 (0.53) GAACYP2C9CYP2C19ALDH1A1PKM
SCHEMBL12449179 0.71 SMN1; SMN2 (0.47) CA1CA2CA12CA9GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed